Deutsche Bank AG Sells 2,162 Shares of CorVel Corp. $CRVL

Deutsche Bank AG lessened its position in shares of CorVel Corp. (NASDAQ:CRVL) by 8.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,075 shares of the business services provider’s stock after selling 2,162 shares during the period. Deutsche Bank AG’s holdings in CorVel were worth $2,472,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its stake in shares of CorVel by 187.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,545,619 shares of the business services provider’s stock worth $171,969,000 after buying an additional 1,007,651 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of CorVel by 198.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 625,612 shares of the business services provider’s stock worth $69,607,000 after buying an additional 415,939 shares during the last quarter. Northern Trust Corp boosted its stake in shares of CorVel by 210.8% during the 4th quarter. Northern Trust Corp now owns 379,743 shares of the business services provider’s stock worth $42,250,000 after buying an additional 257,561 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of CorVel by 2.7% during the 1st quarter. Principal Financial Group Inc. now owns 143,654 shares of the business services provider’s stock worth $16,085,000 after buying an additional 3,818 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of CorVel by 230.2% during the 4th quarter. Janus Henderson Group PLC now owns 136,908 shares of the business services provider’s stock worth $15,233,000 after buying an additional 95,445 shares during the last quarter. Institutional investors own 51.36% of the company’s stock.

CorVel Price Performance

CorVel stock opened at $88.93 on Thursday. The firm has a 50-day moving average of $95.60 and a 200-day moving average of $106.27. CorVel Corp. has a one year low of $85.13 and a one year high of $128.61. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 45.84 and a beta of 0.95.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, August 5th. The business services provider reported $0.52 EPS for the quarter. CorVel had a net margin of 10.98% and a return on equity of 32.31%.

Insiders Place Their Bets

In other CorVel news, insider Maxim Shishin sold 2,400 shares of the stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $108.09, for a total value of $259,416.00. Following the transaction, the insider directly owned 7,050 shares of the company’s stock, valued at $762,034.50. This represents a 25.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark E. Bertels sold 900 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $113.34, for a total transaction of $102,006.00. Following the completion of the transaction, the executive vice president directly owned 2,586 shares in the company, valued at approximately $293,097.24. This represents a 25.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,079 shares of company stock worth $1,446,023 in the last three months. Insiders own 44.56% of the company’s stock.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.